After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Drug Manufacturers – General industry segment, falling under the Healthcare sector. The current market capitalization of Bristol-Myers Squibb Co is $103.16B. A total of 9.6 million shares were traded on the day, compared to an average of 14.46M shares.
In the most recent transaction, Hickey Benjamin sold 97 shares of BMY for 38.01 per share on May 09 ’25. After the transaction, the President, RayzeBio Org. now owns 0 company shares. In a previous transaction on Apr 25 ’25, Hirawat Samit bought 4,250 shares at 47.58 per share. BMY shares that EVP,Chief Med.Offr.,Drug Dev. owns now total 83,513.
Among the insiders who bought shares, BOERNER CHRISTOPHER S. acquired of 2,000 shares on Feb 20 ’25 at a per-share price of $55.05. This resulted in the Chief Executive Officer holding 104,626 shares of BMY after the transaction. In another insider transaction, Hirawat Samit bought 1,823 shares at $54.84 per share on Feb 14 ’25. Company shares held by the EVP,Chief Med.Offr.,Drug Dev. now total 63,932.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Bristol-Myers Squibb Co pays an annual dividend of $2.44, resulting in a dividend yield of 4.81%, and it has a price to earnings (P/E) ratio of 19.03. BMY’s most recent ex-dividend date was 4.14% when it declared a $0.62 quarterly dividend that was paid in cash on 4/4/2025. Previously, the company paid the dividend on 1/3/2025 with an ex-dividend date of 4.38%. The BMY stock dividend was $0.62 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, BMY has a high of $63.33 and a low of $39.35.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. BMY’s latest balance sheet shows that the firm has $17.22B in Cash & Short Term Investments as of fiscal 2021. There were $45.60B in debt and $21.87B in liabilities at the time. Its Book Value Per Share was $8.54, while its Total Shareholder’s Equity was $36.01B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
